<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Between 1989 and 1999, 36 cases with primary <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> were diagnosed </plain></SENT>
<SENT sid="1" pm="."><plain>They were 15 male and 21 females, the median age was 62 years (range: 22 to 90 years) </plain></SENT>
<SENT sid="2" pm="."><plain>Eighty one per cent of patients were presented symptoms of <z:hpo ids='HP_0001903'>anemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0002716'>Lymphadenopathy</z:hpo>, <z:hpo ids='HP_0001744'>splenomegaly</z:hpo> and skin manifestations were noted in 25% of cases </plain></SENT>
<SENT sid="4" pm="."><plain>Hemogram showed <z:hpo ids='HP_0001903'>anemia</z:hpo>, <z:e sem="disease" ids="C0023530" disease_type="Disease or Syndrome" abbrv="">leucopenia</z:e> and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> respectively in 97%, 44% and 55% of cases </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0005505'>Refractory anemia</z:hpo> with excess blasts (AREB) is the most frequent FAB subtypes of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (17 cases) </plain></SENT>
<SENT sid="6" pm="."><plain>Cytogenetic study concerned 24 patients </plain></SENT>
<SENT sid="7" pm="."><plain>In 13 cases the karyotype was pathological with deletion 5 q in 64% of cases </plain></SENT>
<SENT sid="8" pm="."><plain>Seventeen patients have received a chemotherapy </plain></SENT>
<SENT sid="9" pm="."><plain>Survival rate to 36 months is 11% </plain></SENT>
<SENT sid="10" pm="."><plain>At the time, the only curative treatment is the bone marrow transplantation, which is proposed to young patients with HLA identical donor </plain></SENT>
</text></document>